Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (371-380 of 470) with videos related to

Pageof 47
Sort By:
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 30, 2020
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementiaZahinoor Ismail, Sandra E Black, Richard Camicioli, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 21, 2023
Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive DisorderVivian Feng, Krista Lanctot, Nathan Herrmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentYejin Kang, Nathan Herrmann, Damien Gallagher, et al.
Journal of the American Geriatrics Society|April 4, 2017
Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced DementiaJeremy N Matlow, Susan E Bronskill, Andrea Gruneir, et al.
Journal of Medical Internet Research|May 27, 2018
Computer-Based Driving in Dementia Decision Tool With Mail Support: Cluster Randomized Controlled TrialMark J Rapoport, Carla Zucchero Sarracini, Alex Kiss, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2021
Diagnostic Precision in the Detection of Mild Cognitive Impairment: A Comparison of Two ApproachesAndrea M Weinstein, Swathi Gujral, Meryl A Butters, et al.
Journal of Alzheimer'S Disease : JAD|December 31, 2025
Multiscale dispersion entropy of resting-state EEG in older adults with Alzheimer's disease, mild cognitive impairment, and remitted major depressive disorderHamed Azami, Mary P McAndrews, Mostafa Rostaghi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 4, 2023
Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 studyEmily D Clark, Jamie Perin, Nathan Herrmann, et al.
Pageof 47

Showing results (371-380 of 470) with videos related to

Sort By:
Pageof 47
Alzheimer'S Research & Therapy|May 24, 2026
Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trialMyuri Ruthirakuhan, Maya Mills, Paul Rosenberg, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 30, 2020
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementiaZahinoor Ismail, Sandra E Black, Richard Camicioli, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 21, 2023
Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive DisorderVivian Feng, Krista Lanctot, Nathan Herrmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentYejin Kang, Nathan Herrmann, Damien Gallagher, et al.
Journal of the American Geriatrics Society|April 4, 2017
Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced DementiaJeremy N Matlow, Susan E Bronskill, Andrea Gruneir, et al.
Journal of Medical Internet Research|May 27, 2018
Computer-Based Driving in Dementia Decision Tool With Mail Support: Cluster Randomized Controlled TrialMark J Rapoport, Carla Zucchero Sarracini, Alex Kiss, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2021
Diagnostic Precision in the Detection of Mild Cognitive Impairment: A Comparison of Two ApproachesAndrea M Weinstein, Swathi Gujral, Meryl A Butters, et al.
Journal of Alzheimer'S Disease : JAD|December 31, 2025
Multiscale dispersion entropy of resting-state EEG in older adults with Alzheimer's disease, mild cognitive impairment, and remitted major depressive disorderHamed Azami, Mary P McAndrews, Mostafa Rostaghi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 4, 2023
Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 studyEmily D Clark, Jamie Perin, Nathan Herrmann, et al.
Pageof 47